United States · biotech/health
United States · biotech/healthFreenome
Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.
PrivateFor profit
Why reach out now
What the record says about Freenome as a customer or partner.
- Has bought 1 companyIt has done deals before: a sign it is open to partnerships.
Against its peers
Set against 435 biotech/health companies in United States. The ring marks the typical peer.
Across all 5.9M companies: larger than 95% of those with a size listed; older than 5% of those with a founding year; website ranked #2,766,514 in the world, about 6k visits a month.
About Freenome
BiotechnologyHealth CareHealth DiagnosticsPersonal Health
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$1.4B
raised in total, currency not stated across 9 rounds
Last raised Feb 2024, 2 years ago
- Rounds
- 9
- Latest round
- Series unknown
- Investors
- 548 leading
Corporate family
Where it sits in its group, and the deals it has done.
Key facts
Who started it and how it trades.
- Founded by
- Charles Roberts, Gabriel Otte, Michael Otte, Riley Ennis
Every detail we hold
Everything the source datasets list about Freenome, field by field. Contact details are held but never shown.
The company7 fields
- Name
- Freenome
- Type
- For profit
- Status
- Private
- Founded
- 2014
- Founders
- Charles Roberts, Gabriel Otte, Michael Otte, Riley Ennis
- Industry
- biotech/health
- Categories
- Biotechnology, Health Care, Health Diagnostics, Personal Health
Where3 fields
- City
- South San Francisco
- Country
- United States
- Markets
- San Francisco Bay Area, West Coast, Western US
Size and reach3 fields
- Staff band
- 501-1000
- Web traffic rank
- #2,766,514
- Monthly web visits
- 6,234
Show 10 more fieldsShow fewer fields
Funding, as listed7 fields
- Total
- 1,351,550,000 (currency not stated)
- Rounds
- 9
- Latest round
- Series unknown
- Latest round date
- Feb 2024
- Investors
- 54
- Lead investors
- 8
- Listing status
- private
Corporate family1 field
- Acquisitions made
- 1
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Freenome may be growing as it has successfully raised $254 million for its multiomic-based early cancer detection platform. This significant funding round indicates strong investor confidence and the availability of substantial capital to support the company's operations and research. The investment will likely facilitate further development of their cancer detection technology, which could lead to advancements in the biotechnology and health diagnostics industries.
Companies like Freenome
biotech/health in United States.
Revolution MedicinesRedwood City · 251-500 peoplefounded 1 years later
Relay TherapeuticsCambridge · 251-500 peoplefounded 2 years later
Denali TherapeuticsSan Francisco · 251-500 peoplefounded 1 years earlier
SpringWorks TherapeuticsStamford · 251-500 peoplefounded 3 years later
Arcus BiosciencesHayward · 101-250 peoplefounded 1 years laterBuild a lead list
435 biotech/health companies in United States, filtered by size, age and reach, ready to export with emails on Pro.